Vimarsana
Biggest News Aggregation in the World

Page 21 - Breakthrough Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Devices Program Today - Breaking & Trending Today

Bonalive® Biomaterials Ltd. granted FDA Breakthrough Device Designation for a bone graft substitute that potentially protects against microbial colonization - Vimarsana News

Bonalive® Biomaterials Ltd. granted FDA Breakthrough Device Designation for a bone graft substitute that potentially protects against microbial colonization

/PRNewswire/ -- The Center for Devices and Radiological Health at the Food & Drug Administration has determined that Bonalive® Orthopedics granules, made of a...

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion

FREDERICK, Md. and BOSTON, Feb. 15, 2022 /PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regene...

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion

/PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug...

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion

/PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug...

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure - Vimarsana News

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company building a physiological waveform AI platform to manage cardiac disease, announced...